9 Results for "

MOLM-16 cells

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "MOLM-16 cells" in MCE Product Catalog:

Cat. No.: HY-153023
CAS No.: 2429877-78-9
Target:  

PROTACs STAT

Research Areas:  

Cancer

PROTAC STAT3 degrader-2 is a selective and efficacious PROTAC degrader of STAT3 protein with a DC50 of 3.54 μM in Molm-16 Cell. PROTAC STAT3 degrader-2 has the potential for cancer research . PROTAC STAT3 degrader-2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-155066
CAS No.: 2641899-38-7
Purity:  99.45%
Target:  

PI3K mTOR Apoptosis

Research Areas:  

Cancer

FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 arrests HL-60 cell cycle at G1 phase and increases apoptosis. FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research .
loading...
    loading...
Cat. No.: HY-175880
CAS No.: 1644664-11-8
Research Areas:  

Cancer

AMG-34 is a GCN2-targeting agent with IC50 values of 0.395 μM, 0.010 μM, 1.07 μM and > 10 μM for GCN2, PERK, HRland PKR, respectively .
loading...
    loading...
Cat. No.: HY-155529
CAS No.: 1422456-47-0
Target:  

Pim

Research Areas:  

Cancer

FD1024 is PIM inhibitor (IC50s: 1.96, 38.9, 4.17 nM for PIM1, 2, 3). FD1024 can be used for research of acute myeloid leukemia. FD1024 has strong antiproliferative activity against the tested AML cell lines, with 0.16 μM, 0.12 μM, 1.05 μM, 1.39μM for EOL-1, MV-4-11, KG-1, MOLM-16 cells. FD1024 also has antitumor efficacy in mice .
loading...
    loading...
Cat. No.: HY-175877
CAS No.: 2396467-34-6
Research Areas:  

Cancer

RAPT-37-Me is a GCN2-targeting agent with IC50 values of 0.002μM, > 10 μM,4.40 μM and 1.31 μM for GCN2, PERK, HRl and PKR, respectively .
loading...
    loading...
Cat. No.: HY-175878
Research Areas:  

Cancer

EMD-C02602 is a GCN2-targeting agent with IC50 values of 0.023 μM, 4.52 μM, > 10 μM and 0.048 μM for GCN2, PERK, HRland PKR, respectively .
loading...
    loading...
Cat. No.: HY-150895
CAS No.: 2754428-37-8
Research Areas:  

Cancer

SI-191 is a STAT3 inhibitor and a target protein ligand. SI-191 inhibits the growth of cancer cells. SI-191 can be used in the research of acute leukemia and lymphoma. SI-191 can be used for the synthesis of PROTAC SD-91 (HY-150251) .
loading...
    loading...
Cat. No.: HY-184896
CAS No.: 3032314-99-8
XYD113 is an orally active, selective GSPT1 Molecular glue degrader. XYD113 promotes the formation of the CRBN-GSPT1 ternary complex and mediates GSPT1 degradation in a CRBN-dependent manner via the ubiquitin-proteasome system. XYD113 downregulates genes associated with the occurrence and progression of prostate cancer (c-Myc, AR, AR-V7, KLK3, KLK2, TMPRSS2). XYD113 exhibits anticancer activity against prostate cancer. XYD113 can be used in the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-181959
CAS No.: 2752441-61-3
Research Areas:  

Cancer

APL-4098 is an orally active, selective, ATP-competitive GCN2 inhibitor with a Ki of 4.39 nM and a Kd of 2.9 nM. APL-4098 reduces the phosphorylation level of eIF2α and the expression level of ATF4. APL-4098 impairs mitochondrial function and exerts cytotoxic effects on primary acute myeloid leukemia cells. APL-4098 is applicable to research related to acute myeloid leukemia .
loading...
    loading...